நிடின் நாயக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நிடின் நாயக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நிடின் நாயக் Today - Breaking & Trending Today

Next Generation Biopharmaceutical Manufacturing


Next Generation Biopharmaceutical Manufacturing
According to a new Frost and Sullivan report, “Preparing for Next Generation of Biopharmaceutical Manufacturing,” the bioindustry industry is facing “its biggest test in recent times” due to new disease outbreaks, the urgency for innovative therapies, and the emergence of non-traditional products such as bispecific antibodies and cellular therapies. Biopharma will be compelled “to adopt new manufacturing approaches.”
Primary drivers include cost reduction and scalability, particularly for downstream operations. Biopharmaceutical developers can achieve these benefits by “adopting advanced manufacturing technologies, establishing public-private partnerships and placing sustainability at the core of the business strategy.”
The Frost & Sullivan study analyzes six “dynamic trends” that will revolutionize business-as-usual, including adopting new technologies and next-generation manufacturing methods, optimi ....

Nitin Naik , Next Generation , Biopharmaceutical Manufacturing , நிடின் நாயக் , அடுத்தது ஜெநரேஶந் ,

Discover Six Dynamic Trends to Disrupt the Next Generation of Biopharmaceutical Manufacturing


Discover Six Dynamic Trends to Disrupt the Next Generation of Biopharmaceutical Manufacturing
USA - English
Share this article
Share this article
Technology, industry collaborations and a desire to innovate will help participants sustain their growth momentum and achieve manufacturing scale, finds Frost & Sullivan
SANTA CLARA, Calif., May 12, 2021 /PRNewswire/  The biopharmaceutical industry is facing its biggest test in recent times. A rise in new disease outbreaks, the urgency to launch innovative therapies, and new constructs such as multi-valent antibodies are compelling biopharmaceutical companies to adopt new manufacturing approaches. The industry must reduce costs and achieve scalability of downstream processes in global sites to work more efficiently. Biopharmaceutical companies must follow suit by adopting advanced manufacturing technologies, establishing public-private partnerships and placing sustainability at the core of the business strategy. ....

Nitin Naik , Mariana Fernandez , Global Practice Area Leader Healthcare Life Sciences , Corporate Communications , Matt Peters Application Development Specialist , Next Generation , Biopharmaceutical Manufacturing , Global Practice Area Leader , Life Sciences , Matt Peters , Application Development Specialist , Mega Trends , Frost Amp Sullivan , நிடின் நாயக் , மரியானா பெர்னாண்டஸ் , பெருநிறுவன தகவல்தொடர்புகள் , அடுத்தது ஜெநரேஶந் , வாழ்க்கை அறிவியல் , மேட் பீட்டர்ஸ் , விண்ணப்பம் வளர்ச்சி நிபுணர் , மெகா போக்குகள் , பனி ஆம்ப் சல்லிவன் ,